Abstract
Amiodarone, used in conjunction with percutaneous balloon mitral commissurotomy, can safely convert rheumatic atrial fibrillation in 38% of patients compared with 0% in those without it. However, whether this treatment exerts long-term benefits on prognosis awaits further investigation.
Publication types
-
Clinical Trial
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amiodarone / adverse effects
-
Amiodarone / therapeutic use*
-
Anti-Arrhythmia Agents / adverse effects
-
Anti-Arrhythmia Agents / therapeutic use*
-
Atrial Fibrillation / drug therapy*
-
Atrial Fibrillation / etiology
-
Catheterization*
-
Combined Modality Therapy
-
Female
-
Humans
-
Male
-
Middle Aged
-
Mitral Valve Stenosis / etiology
-
Mitral Valve Stenosis / surgery*
-
Prospective Studies
-
Rheumatic Heart Disease / complications
-
Rheumatic Heart Disease / therapy*
Substances
-
Anti-Arrhythmia Agents
-
Amiodarone